Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China

被引:18
|
作者
Feng, Jin-ge [1 ]
Guo, Yan [2 ]
Ma, Li-ang [3 ]
Xing, Jin [4 ]
Sun, Rui-feng [5 ]
Zhu, Wei [5 ]
机构
[1] Capital Med Univ, Fu Xing Hosp, Dept Dermatol, Beijing, Peoples R China
[2] Capital Med Univ, Fu Xing Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
[3] Hlth Care Inst, Primary & Middle Sch, Dept Phys Examinat, Beijing, Peoples R China
[4] Capital Med Univ, Fu Xing Hosp, Dept Ultrasonog, Beijing, Peoples R China
[5] Capital Med Univ, Xuan Wu Hosp, Dept Dermatol, Beijing, Peoples R China
关键词
acne; androgenic alopecia; hirsutism; hyperandrogenism; metabolic biomarker; polycystic ovary syndrome; FREE ANDROGEN INDEX; PATTERN HAIR LOSS; INSULIN-RESISTANCE; TESTOSTERONE; HIRSUTISM; STATEMENT; ETHNICITY; FEATURES; CRITERIA;
D O I
10.1111/jocd.12387
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundCutaneous features of hyperandrogenism in polycystic ovary syndrome (PCOS) include acne, hirsutism, seborrhea, androgenic alopecia (AGA), and acanthosis nigricans (AN). However, the relationships have not been well known broadly in terms of clinical hyperandrogenism and biochemical markers. ObjectivesThe aim of this study was to investigate biochemical and metabolic parameters in relation to cutaneous characters women in with and without PCOS. Methods: This was a cross-sectional retrospective study including 186 women with PCOS and 113 age-matched without PCOS women. Acne grade, hirsutism, seborrhea, AGA, and AN were recorded. Hormonal and metabolic parameters were measured. ResultsThe most common finding was acne, and AN was the least dermatological manifestations between PCOS and non-PCOS groups. The severity location and type of acne did not differ in PCOS women compared to non-PCOS women. Significant differences were found with respect to free androgen index (FAI) (P=.036), sex hormone-binding globulin (SHBG) (P=.023), and body mass index (BMI) (P=.001) between PCOS with acne and PCOS without acne groups. Overall, age (P=.005) was significantly decreased, while BMI (P=.004) was significantly higher in PCOS with hirsutism. The mean serum total testosterone (TT), dehydroepiandrosterone sulfate, and FAI were significantly elevated, but SHBG was decreased between PCOS with and without hirsutism groups. There were significantly different BMI (P=.018) and triglyceride (P=.024) except other hormonal parameter of without AGA group. ConclusionThis study indicated a strong correlation between hirsutism and metabolic abnormalities. Hirsutism is the most common cutaneous finding in PCOS women. Acne and AGA are associated with other manifestations of clinical hyperandrogenism, but not obvious markers of biochemical hyperandrogenemia and metabolic dysfunction.
引用
收藏
页码:511 / 517
页数:7
相关论文
共 50 条
  • [1] Dermatologic manifestations of polycystic ovary syndrome
    Lee, Amy T.
    Zane, Lee T.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2007, 8 (04) : 201 - 219
  • [2] Dermatologic Manifestations of Polycystic Ovary Syndrome
    Amy T. Lee
    Lee T. Zane
    [J]. American Journal of Clinical Dermatology, 2007, 8 : 201 - 219
  • [3] Prevalence of metabolic syndrome in women with polycystic ovary syndrome
    Panidis, Dimitrios
    Macut, Djuro
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    Mikhailidis, Konstantinos
    Kandaraki, Eleni A.
    Tsourdi, Elena A.
    Tantanasis, Theoharis
    Mavromatidis, George
    Katsikis, Ilias
    [J]. CLINICAL ENDOCRINOLOGY, 2013, 78 (04) : 586 - 592
  • [4] Prevalence of metabolic syndrome in women with polycystic ovary syndrome
    Popovic, B.
    Macut, D.
    Bozic, I.
    Petakov, M.
    Ognjanovic, S.
    Isailovic, T.
    Damjanovic, S.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 426 - 427
  • [5] Prevalence of the metabolic syndrome in women with polycystic ovary syndrome
    Bregieiro Fernandes Costa, Laura Olinda
    Ribeiro Viana, Aline de Oliveira
    de Oliveira, Monica
    [J]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2007, 29 (01): : 10 - 17
  • [6] Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
    Lowenstein, Eve J.
    [J]. DERMATOLOGIC THERAPY, 2006, 19 (04) : 210 - 223
  • [7] Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
    Apridonidze, T
    Essah, PA
    Iuorno, MJ
    Nestler, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04): : 1929 - 1935
  • [8] Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome
    Ehrmann, DA
    Liljenquist, DR
    Kasza, K
    Azziz, R
    Legro, RS
    Ghazzi, MN
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01): : 48 - 53
  • [9] Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome
    Hahn, S.
    Tan, S.
    Sack, S.
    Kimmig, R.
    Quadbeck, B.
    Mann, K.
    Janssen, O. E.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (02) : 130 - 135
  • [10] Metabolic syndrome in women with polycystic ovary syndrome: Prevalence, characteristics and predictors
    Marcondes, Jose Antonio M.
    Hayashida, Sylvia A. Y.
    Barcellos, Cristiano R. G.
    Rocha, Michelle P.
    Maciel, Gustavo A. R.
    Baracat, Edmund C.
    [J]. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (06) : 972 - 979